Announcing: A new milestone to strengthen U.S. readiness for critical medicines.
Today, Angels for Change and Medivant Healthcare announced the completion of a key Project PROTECT milestone, establishing ready-to-activate U.S. manufacturing capacity for 10% Calcium Chloride Injection, an essential medicine used in emergency and critical care.
Through the partnership, Medivant has completed development of Calcium Chloride Injection and advanced the medicine into Project PROTECT’s readiness phase, creating domestic manufacturing capacity that can be activated when supply disruptions threaten patient access.
“Project PROTECT is about staying ahead of shortages before they reach patients,” said Laura Bray, Chief Change Maker at Angels for Change. “By partnering with Medivant Healthcare to prepare domestic capacity for Calcium Chloride Injection, we are demonstrating what proactive shortage preparedness can look like and building the ability to respond before a supply disruption becomes a patient crisis.”
Since launching in 2022, Project PROTECT has strengthened U.S. readiness for 14 essential medicines, seven of which have subsequently experienced shortages, with more than 850,000 patient treatments accessed during shortages.
For the first time since 2019, Abby Bray is sharing her cancer journey in her own words.
For years, Abby kept her story private. Now, five years cancer-free, she is choosing to share her experience and use her voice to advocate for other patients facing drug shortages.
Abby was Patient One for Angels for Change.
Today, she is helping carry that mission forward as a member of the Angels for Change Patient Advocacy Board, which brings patients, caregivers, and lived experiences directly into our advocacy work.
Angels for Change (A4C) successfully concluded its sold out SummitONE 2026, its annual healthcare summit focused on strengthening pharmaceutical supply chain resilience, at Pfizer's headquarters in New York City. The two-day event brought together executives and experts from across the pharmaceutical ecosystem; including manufacturers, distributors, healthcare systems, regulators, policymakers, and patient advocates. SummitONE advances collaboration and actionable solutions to strengthen access to medicines and end drug shortages.
Project GOLD is growing. Building on the success of its groundbreaking first phase, Angels for Change has launched Project GOLD Phase 2, expanding the nation's first collaborative initiative designed to protect cancer patients from drug shortages. With new manufacturer and distributor partners and an expanded portfolio of 15 high-risk oncology medicines, Phase 2 strengthens a proven model built on strategic U.S.-based buffer supply, early warning systems, and cross-sector collaboration. Following the successful protection of patient access during the national leucovorin shortage, Project GOLD continues to demonstrate that when industry leaders unite around a shared commitment to patients, together we can build a more resilient pharmaceutical supply chain and help ensure lifesaving cancer treatments remain available when patients need them most.
Tampa, FL [March 16, 2023] Angels for Change is excited to announce Chief Change Maker, Laura Bray as the recipient of The Society of Gynecologic Oncology (SGO) 2023-2024 Service Award! This accolade recognized Bray's dedication and contributions to the field of gynecologic oncology and her unwavering commitment to advancing patient care.
Angels for Change is proud to be a Member of the US Pharmacopeia Convention and part of their Drug Shortage Task Force. We support their call to action to solve drug shortages. Our work together is a movement for a total systemic shift in short and long-term solutions that will protect all patients in need of life-saving treatments.
TAMPA, Fla, February 1, 2024 - Laura Bray, founder and Chief Change Maker of patient advocacy group Angels for Change issued a statement on the new plan released by the Senate Finance Committee leadership on solutions for drug shortages
Last week, API Innovation Center released, "A Bold Goal: Reshoring 25% of Small Molecule API To The U.S. in 5 Years" white paper to the White House Office of Science and Technology. Angels for Change is proud to be a contributor on this important work and represent the patient perspective in solutions.
The Daily Mail and Alexa Lardieri covered the impact drug shortages are having on US patients and highlighted the Change Maker Movement.
SHARE YOUR “WHY”
Every conversation, partnership, and shared story brings us closer to a future without drug shortages. At Angels for Change, we’re proud to march forth for patients everywhere.
